(Q28364195)

https://api.crossref.org/works/10.1136/JNNP.37.4.422

10 March 2023

3

C D Marsden

0 references

author name string

J. D. Parkes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4838913

10 March 2023

R. C. Baxter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4838913

10 March 2023

C. D. Marsden

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4838913

10 March 2023

J. E. Rees

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4838913

full work available at URL

10 March 2023

language of work or name

English

0 references

publication date

April 1974

0 references

https://europepmc.org/articles/PMC494673

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4838913

https://europepmc.org/articles/PMC494673?pdf=render

10 March 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4838913

https://syndication.highwire.org/content/doi/10.1136/jnnp.37.4.422

10 March 2023

1 reference

Crossref

DOI

10.1136/JNNP.37.4.422

https://api.crossref.org/works/10.1136/JNNP.37.4.422

Journal of Neurology, Neurosurgery and Psychiatry

10 March 2023

published in

0 references

volume

37

0 references

issue

4

0 references

page(s)

422-6

0 references

cites work

A REVIEW OF DRUG THERAPY IN PARKINSONISM

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=494673

Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=494673

Drug Therapy of Parkinsonism

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=494673

Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=494673

On the mode of action of amantadine

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=494673

Cholinergic-anticholinergic antagonism in parkinsonism.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=494673

Modification of Parkinsonism--chronic treatment with L-dopa

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=494673

Amantadine in Parkinsonism.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=494673

Idiopathic Parkinsonism Treated with an Extracerebral Decarboxylase Inhibitor in Combination with Levodopa

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=494673

Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=494673

Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease

27 November 2018

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Levodopa in Parkinsonism: the Effects of Withdrawal of Anticholinergic Drugs

1 reference

PubMed

12 December 2020

The continued use of amantadine hydrochloride in parkinsonism

1 reference

PubMed

12 December 2020

1 reference

12 December 2020

Identifiers

DOI

10.1136/JNNP.37.4.422

0 references

PMC publication ID

494673

0 references